Citadel Advisors’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,357
| Closed | -$3.2K | – | 6821 |
|
|
2025
Q1 | $3.2K | Buy |
+3,357
| New | +$3.2K | ﹤0.01% | 5757 |
|
|
2024
Q4 | – | Sell |
-13,508
| Closed | -$19.5K | – | 6657 |
|
|
2024
Q3 | $19.5K | Buy |
+13,508
| New | +$19.5K | ﹤0.01% | 5341 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6683 |
|
|
2024
Q1 | – | Sell |
-45,255
| Closed | -$233K | – | 6741 |
|
|
2023
Q4 | $233K | Buy |
45,255
+35,621
| +370% | +$183K | ﹤0.01% | 4456 |
|
|
2023
Q3 | $47K | Sell |
9,634
-73,587
| -88% | -$359K | ﹤0.01% | 5095 |
|
|
2023
Q2 | $488K | Buy |
83,221
+79,695
| +2,260% | +$467K | ﹤0.01% | 3668 |
|
|
2023
Q1 | $14.8K | Buy |
+3,526
| New | +$14.8K | ﹤0.01% | 5450 |
|
|
2022
Q4 | – | Sell |
-40,232
| Closed | -$64K | – | 6614 |
|
|
2022
Q3 | $64K | Buy |
+40,232
| New | +$64K | ﹤0.01% | 5240 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6786 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7006 |
|
|
2021
Q2 | – | Sell |
-36,652
| Closed | -$210K | – | 6990 |
|
|
2021
Q1 | $210K | Buy |
+36,652
| New | +$210K | ﹤0.01% | 5366 |
|